Six grantees of the ACAAI Community Grant Projects will share their project outcomes at the ACAAI Annual Scientific Meeting in Orlando. The grants support innovative initiatives designed to tackle ...

New research shows that early peanut introduction at 4 to 11 months reduces peanut allergies by 43% in children under 3, challenging old guidelines that waited until age 3.

Two new studies appearing in Annals of Allergy Asthma & Immunology and being presented at the American College of Allergy, ...

A US study found peanut allergy diagnoses decreased 43% in the years after guidelines changed to recommend introducing these ...

Now, looking at the data, it’s clear that delaying the introduction of peanuts led to the alarming rise in peanut allergy.

According to researchers, this simple idea has protected more than 60,000 people from getting peanut allergies.

AbbVie posts strong Q3 results with $7.89B immunology sales, rising Elahere revenue, and Rinvoq Phase 3 success. Learn why ABBV stock is a strong buy.

New research suggests the COVID-19 vaccine could help children with eczema stay healthier overall. Vaccinated kids had lower ...

These companies have exceptional dividend track records. AbbVie is moving on from its Humira patent losses, and its portfolio ...

From rare tick-borne meat allergy to everyday asthma, millions of people turn to social media for health advice. But new ...

Herpafend operates through a multi-layered biological support system that focuses on immune strengthening, viral suppression, ...

Critics, including some drugmakers, argue that new patent policies would make it more difficult for companies to bring ...